[1] VEENENDAAL G H,WAAL M D.Uncoupling activity of the anthelmintic oxyclozanide in rodents[J].Br J Pharmacol,1974, 50(3):435-437. [2] 吴小曼,纪宇.比色法测定复方氨基酸注射液(18AA-Ⅰ)中焦亚硫酸钠的含量[J].中国药品标准,2007,8(5):38-40. [3] 梁艳利,张慧丽,吴拥军.光度法测定依达拉奉注射液中抗氧剂焦亚硫酸钠的含量[J].河南科学,2010,28(11):1403-1404. [4] 赵明,张娟,高锦,等.胞磷胆碱钠注射液中辅料焦亚硫酸钠的含量测定[J].药学服务与研究,2012,12(6):450. [5] 郑稳生,王璐璐,陈少华,等.紫外分光光度法测定长春西汀注射液中焦亚硫酸钠含量[J].医药导报,2012,31(8):1082-1083. [6] MARÍA A V,MERCEDES S,MARIA M,et al. Risk of gallstone disease in advanced chronic phase of fascioliasis:An experimental study in a rat model[J].Journal of Infectious Diseases,2003,188(5):787-793. [7] 张克勤,陈宝杰,张克志,等.宾川县片形吸虫感染疫情的调查报告[J].卫生软科学,2013,27(3):164-166. [8] 王永怡,张云辉,王姝,等.2014年传染病相关热点回顾[J].传染病信息,2015,28(1):3-8. [9] FAIRWEATHER I,BORAY J C.Fasciolicides efficacy,actions resistance and its management[J].The Veterinary Journal,1999, 158(2):81-112. [10] OVEREND D J,BOWEN F L.Resistance of fasciola hepatica to triclabendazole[J]. Aust Vet J,1995,727(2):75. |